Malaria is a life-threatening disease that is transmitted through the bite of infected anopheles mosquitos. The infected mosquitos transmit the plasmodium parasite into the bloodstream of human body upon being bitten. As the parasite enters the human body, it travels around the body to affect the liver and matures with time. Upon attaining maturity, the parasite enters the bloodstream to infect the red blood cells in the body. This causes individuals suffering from malaria to frequently experience headache, vomiting, fever, and weakness.
The global malaria diagnostics market is anticipated to exhibit a CAGR of 28% during the assessment period between 2018 and 2023. It is reported in a study released by Market Research Future (MRFR), that the market is positively influenced by a number of factors. A major factor influencing this growth is the increasing advancements in technology related to diagnostic tools and the proliferating demand for such treatments in malaria-endemic countries. Other factors driving the market growth are rising support from the government in terms of investment funds and an increase in the collaboration between the research centers and the industry. Malaria diagnostic tests play a significant role in identifying malarial cases, which thereby boosts the growth of the overall malaria diagnostic market.
Market Segmentation
The global malaria diagnostics market segmentation is done as per technology and end-user.
By technology, the market is divided into microscopy, molecular diagnostic tests, and rapid diagnostic tests. Furthermore, the molecular diagnostic test is narrowed down into real-time polymerase chain reaction (RT-PCR) and polymerase chain reaction (PCR).
By end-users, the market comprises of clinics, hospitals, community healthcare, and others.
Regional Analysis
Geographically, the global malaria diagnostic market covers regions such as North America, European, Asia Pacific, and Middle East Africa.
The North American region holds the largest share of the malaria diagnostic market and leads the global standings. The region is further expected to garner the largest market share during the forecast period 2018 and 2023. The market is slated for growth due to the rise in awareness, advancing medical technologies, favorable compensation setting for various surgical methods and procedures, medical tourism, and expanding growth of the healthcare sector.
Competitive Landscape
The global malaria diagnostics market comprises of a number of key and prominent players, including Leica Microsystems GmbH, Premier Medical Corporation Pvt. Ltd, Access Bio. Inc., Beckman Coulter Inc., bioMérieux, Nikon Corporation, Abbott Laboratories, Olympus Corporation, Sysmex Partec GmbH, Siemens Healthineers, and Bio-Rad Laboratories Inc.
March 28th, 2019, Global Health Innovative Technology Fund announced a total of 2.86 Billion Yen to aid 10 partnerships to research and develop new lifesaving drugs, diagnosis, and vaccines for disorders like Vaccines for Leishmaniasis and Malaria, Schistosomiasis, Malaria, Tuberculosis, Dengue, and Diagnostics.
Jan 2nd, 2019, ERADA Technology Alliance LTD, one of the leaders of innovative, rapid diagnostic solutions for early stage detection of infectious diseases, announced the launch of one of the world’s first diagnostic saliva test for malaria.
Browse Full Report Details @ https://www.marketresearchfuture.com/reports/malaria-diagnosis-treatment-market-2952
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.
